HEADER TRANSFERASE 02-SEP-14 4UYO TITLE STRUCTURE OF DELTA7-DGKA IN 7.9 MAG BY SERIAL FEMTOSECOND TITLE 2 CRYSTATALLOGRAPHY TO 2.18 ANGSTROM RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIACYLGLYCEROL KINASE-DELTA 7; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: DAGK, DIGLYCERIDE KINASE, DGK, DIACYLGLYCEROL KINASE-DELTA7; COMPND 5 EC: 2.7.1.107; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K12; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 ATCC: 29425; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: WH1061; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PTRCHISB; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PTRCHISB-DGKA-DELTA7 KEYWDS TRANSFERASE, 7.9 MAG, IN MESO CRYSTALLIZATION, LIPID CUBIC PHASE, KEYWDS 2 LIPIDIC CUBIC PHASE, LIPID MESOPHASE, LIPIDIC MESOPHASE, MEMBRANE KEYWDS 3 PROTEIN, MICROCRYSTALS, MONOACYLGLYCEROL, ROOM TEMPERATURE KEYWDS 4 CRYSTALLOGRAPHY, SERIAL FEMTOSECOND CRYSTALLOGRAPHY, X-RAY FREE- KEYWDS 5 ELECTRON LASER EXPDTA X-RAY DIFFRACTION AUTHOR D.LI,N.HOWE,O.OTHER,M.CAFFREY REVDAT 7 10-JAN-24 4UYO 1 REMARK LINK REVDAT 6 08-MAY-19 4UYO 1 REMARK REVDAT 5 06-MAR-19 4UYO 1 REMARK REVDAT 4 14-NOV-18 4UYO 1 REMARK REVDAT 3 17-JAN-18 4UYO 1 REMARK REVDAT 2 13-JAN-16 4UYO 1 JRNL REVDAT 1 30-SEP-15 4UYO 0 JRNL AUTH D.LI,P.J.STANSFELD,M.S.P.SANSOM,A.KEOGH,L.VOGELEY,N.HOWE, JRNL AUTH 2 J.A.LYONS,D.ARAGAO,P.FROMME,R.FROMME,S.BASU,I.GROTJOHANN, JRNL AUTH 3 C.KUPITZ,K.RENDEK,U.WEIERSTALL,N.A.ZATSEPIN,V.CHEREZOV, JRNL AUTH 4 W.LIU,S.BANDARU,N.J.ENGLISH,C.GATI,A.BARTY,O.YEFANOV, JRNL AUTH 5 H.N.CHAPMAN,K.DIEDERICHS,M.MESSERSCHMIDT,S.BOUTET, JRNL AUTH 6 G.J.WILLIAMS,M.MARVIN SEIBERT,M.CAFFREY JRNL TITL TERNARY STRUCTURE REVEALS MECHANISM OF A MEMBRANE JRNL TITL 2 DIACYLGLYCEROL KINASE. JRNL REF NAT.COMMUN. V. 6 10140 2015 JRNL REFN ESSN 2041-1723 JRNL PMID 26673816 JRNL DOI 10.1038/NCOMMS10140 REMARK 2 REMARK 2 RESOLUTION. 2.18 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.18 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.01 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 51797 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2583 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.0197 - 5.7080 0.99 2940 144 0.2300 0.2344 REMARK 3 2 5.7080 - 4.5326 1.00 2798 161 0.2163 0.2347 REMARK 3 3 4.5326 - 3.9603 1.00 2792 133 0.1548 0.1631 REMARK 3 4 3.9603 - 3.5984 1.00 2771 131 0.1771 0.2287 REMARK 3 5 3.5984 - 3.3406 1.00 2783 129 0.1868 0.2367 REMARK 3 6 3.3406 - 3.1438 1.00 2722 145 0.1962 0.2650 REMARK 3 7 3.1438 - 2.9864 1.00 2760 146 0.1881 0.2598 REMARK 3 8 2.9864 - 2.8564 1.00 2738 141 0.1932 0.2426 REMARK 3 9 2.8564 - 2.7465 1.00 2723 150 0.2010 0.2689 REMARK 3 10 2.7465 - 2.6517 1.00 2715 130 0.2170 0.2737 REMARK 3 11 2.6517 - 2.5688 1.00 2694 147 0.2385 0.2579 REMARK 3 12 2.5688 - 2.4954 1.00 2707 160 0.2693 0.3230 REMARK 3 13 2.4954 - 2.4297 1.00 2686 151 0.2971 0.3319 REMARK 3 14 2.4297 - 2.3705 1.00 2700 158 0.3126 0.3623 REMARK 3 15 2.3705 - 2.3166 1.00 2737 126 0.3329 0.3925 REMARK 3 16 2.3166 - 2.2673 1.00 2681 150 0.3446 0.3881 REMARK 3 17 2.2673 - 2.2219 0.99 2676 136 0.3563 0.3415 REMARK 3 18 2.2219 - 2.1800 0.96 2591 145 0.3772 0.3867 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.730 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 71.31 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 70.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 5244 REMARK 3 ANGLE : 0.949 7132 REMARK 3 CHIRALITY : 0.057 855 REMARK 3 PLANARITY : 0.003 873 REMARK 3 DIHEDRAL : 13.963 1927 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THERE ARE SIX NCS-RELATED MOLECULES IN REMARK 3 THE ASYMMETRIC UNIT BUT NCS RESTRAINTS WERE NOT USED IN THE REMARK 3 REFINEMENT. REMARK 4 REMARK 4 4UYO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1290061564. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAR-13 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 140440 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : FREE ELECTRON LASER REMARK 200 BEAMLINE : CXI REMARK 200 X-RAY GENERATOR MODEL : SLAC LCLS BEAMLINE CXI REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.302 REMARK 200 MONOCHROMATOR : K-B MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : CORNELL-SLAC PIXEL ARRAY REMARK 200 DETECTOR (CSPAD) REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTFEL REMARK 200 DATA SCALING SOFTWARE : CRYSTFEL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54058 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.180 REMARK 200 RESOLUTION RANGE LOW (A) : 40.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -5.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3466. REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.18 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3519. REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.440 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3ZE3 REMARK 200 REMARK 200 REMARK: R SPLIT (I) 0.07, R SPLIT FOR SHELL (I) 2.38 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 %(V/V) 2-METHYL-2, 4-PENTANEDIOL REMARK 280 (MPD), 0.1 M SODIUM CHLORIDE, 0.1 M SODIUM CITRATE/HCL PH 5.6. REMARK 280 CRYSTALLIZED USING THE IN MESO (LIPID CUBIC PHASE) METHOD AT 20 REMARK 280 DEGREES CELCIUS WITH THE 7.9 MONOACYLGLYCEROL (7.9 MAG) AS THE REMARK 280 HOSTING LIPID.CRYSTALLIZATION WAS SET UP BY INCUBATING 20 REMARK 280 MICROLITERS OF LIPID CUBIC PHASE WITH 400 MICROLITERS OF REMARK 280 PRECIPITANT SOLUTION IN COUPLED SYRINGES., LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.65000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.85000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.90000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.85000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.65000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.90000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLU A -1 REMARK 465 LEU A 0 REMARK 465 ALA A 1 REMARK 465 ASN A 2 REMARK 465 ASN A 3 REMARK 465 THR A 4 REMARK 465 THR A 5 REMARK 465 GLY B -8 REMARK 465 HIS B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 GLU B -1 REMARK 465 LEU B 0 REMARK 465 ALA B 1 REMARK 465 ASN B 2 REMARK 465 ASN B 3 REMARK 465 THR B 4 REMARK 465 THR B 5 REMARK 465 GLY B 6 REMARK 465 PHE B 7 REMARK 465 THR B 8 REMARK 465 ARG B 9 REMARK 465 ILE B 10 REMARK 465 ILE B 11 REMARK 465 LYS B 12 REMARK 465 ALA B 13 REMARK 465 ALA B 14 REMARK 465 GLY B 15 REMARK 465 TYR B 16 REMARK 465 SER B 17 REMARK 465 TRP B 18 REMARK 465 LYS B 19 REMARK 465 GLY B 20 REMARK 465 LEU B 21 REMARK 465 ARG B 22 REMARK 465 ALA B 23 REMARK 465 GLY C -8 REMARK 465 HIS C -7 REMARK 465 HIS C -6 REMARK 465 HIS C -5 REMARK 465 HIS C -4 REMARK 465 HIS C -3 REMARK 465 HIS C -2 REMARK 465 GLU C -1 REMARK 465 LEU C 0 REMARK 465 ALA C 1 REMARK 465 ASN C 2 REMARK 465 ASN C 3 REMARK 465 THR C 4 REMARK 465 THR C 5 REMARK 465 GLY C 6 REMARK 465 PHE C 7 REMARK 465 THR C 8 REMARK 465 ARG C 9 REMARK 465 ILE C 10 REMARK 465 ILE C 11 REMARK 465 LYS C 12 REMARK 465 ALA C 13 REMARK 465 ALA C 14 REMARK 465 GLY C 15 REMARK 465 TYR C 16 REMARK 465 SER C 17 REMARK 465 TRP C 18 REMARK 465 LYS C 19 REMARK 465 GLY C 20 REMARK 465 LEU C 21 REMARK 465 ARG C 22 REMARK 465 ALA C 23 REMARK 465 ALA C 24 REMARK 465 TRP C 25 REMARK 465 ILE C 26 REMARK 465 ASN C 27 REMARK 465 GLU C 28 REMARK 465 ALA C 29 REMARK 465 ALA C 30 REMARK 465 PHE C 31 REMARK 465 GLY D -8 REMARK 465 HIS D -7 REMARK 465 HIS D -6 REMARK 465 HIS D -5 REMARK 465 HIS D -4 REMARK 465 HIS D -3 REMARK 465 HIS D -2 REMARK 465 GLU D -1 REMARK 465 LEU D 0 REMARK 465 ALA D 1 REMARK 465 ASN D 2 REMARK 465 ASN D 3 REMARK 465 THR D 4 REMARK 465 THR D 5 REMARK 465 GLY D 6 REMARK 465 PHE D 7 REMARK 465 THR D 8 REMARK 465 ARG D 9 REMARK 465 ILE D 10 REMARK 465 ILE D 11 REMARK 465 LYS D 12 REMARK 465 ALA D 13 REMARK 465 GLY E -8 REMARK 465 HIS E -7 REMARK 465 HIS E -6 REMARK 465 HIS E -5 REMARK 465 HIS E -4 REMARK 465 HIS E -3 REMARK 465 HIS E -2 REMARK 465 GLU E -1 REMARK 465 LEU E 0 REMARK 465 ALA E 1 REMARK 465 ASN E 2 REMARK 465 ASN E 3 REMARK 465 THR E 4 REMARK 465 THR E 5 REMARK 465 GLY E 6 REMARK 465 PHE E 7 REMARK 465 THR E 8 REMARK 465 ARG E 9 REMARK 465 ILE E 10 REMARK 465 ILE E 11 REMARK 465 LYS E 12 REMARK 465 ALA E 13 REMARK 465 ALA E 14 REMARK 465 GLY E 15 REMARK 465 ASN E 27 REMARK 465 GLU E 28 REMARK 465 ALA E 29 REMARK 465 ALA E 30 REMARK 465 PHE E 31 REMARK 465 GLY F -8 REMARK 465 HIS F -7 REMARK 465 HIS F -6 REMARK 465 HIS F -5 REMARK 465 HIS F -4 REMARK 465 HIS F -3 REMARK 465 HIS F -2 REMARK 465 GLU F -1 REMARK 465 LEU F 0 REMARK 465 ALA F 1 REMARK 465 ASN F 2 REMARK 465 ASN F 3 REMARK 465 THR F 4 REMARK 465 THR F 5 REMARK 465 GLY F 6 REMARK 465 PHE F 7 REMARK 465 THR F 8 REMARK 465 ARG F 9 REMARK 465 ILE F 10 REMARK 465 ILE F 11 REMARK 465 LYS F 12 REMARK 465 ALA F 13 REMARK 465 ALA F 14 REMARK 465 GLY F 15 REMARK 465 TYR F 16 REMARK 465 SER F 17 REMARK 465 TRP F 18 REMARK 465 LYS F 19 REMARK 465 GLY F 20 REMARK 465 LEU F 21 REMARK 465 ARG F 22 REMARK 465 ALA F 23 REMARK 465 ALA F 24 REMARK 465 TRP F 25 REMARK 465 GLY F 121 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 27 46.50 -89.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN D1122 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU D 28 OE1 REMARK 620 2 GLU D 28 OE2 62.1 REMARK 620 3 GLU D 76 OE1 129.7 81.4 REMARK 620 4 GLU D 76 OE2 164.3 133.4 62.5 REMARK 620 5 FLC D1126 OA2 104.0 112.1 122.0 70.1 REMARK 620 6 HOH D2004 O 81.7 143.3 122.2 83.0 80.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 79N A 1122 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 79M B 1122 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 79N B 1123 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 79M B 1124 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 79N C 1122 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 79N D 1123 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 79N D 1124 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 79M D 1125 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 79M F 1121 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN D 1122 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FLC D 1126 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UXW RELATED DB: PDB REMARK 900 STRUCTURE OF DELTA4-DGKA-APO IN 9.9 MAG REMARK 900 RELATED ID: 4UXX RELATED DB: PDB REMARK 900 STRUCTURE OF DELTA4-DGKA WITH AMPPCP IN 9.9 MAG REMARK 900 RELATED ID: 4UXZ RELATED DB: PDB REMARK 900 STRUCTURE OF DELTA7-DGKA-SYN IN 7.9 MAG TO 2.18 ANGSTROM RESOLUTION DBREF 4UYO A 1 121 UNP P0ABN1 KDGL_ECOLI 2 122 DBREF 4UYO B 1 121 UNP P0ABN1 KDGL_ECOLI 2 122 DBREF 4UYO C 1 121 UNP P0ABN1 KDGL_ECOLI 2 122 DBREF 4UYO D 1 121 UNP P0ABN1 KDGL_ECOLI 2 122 DBREF 4UYO E 1 121 UNP P0ABN1 KDGL_ECOLI 2 122 DBREF 4UYO F 1 121 UNP P0ABN1 KDGL_ECOLI 2 122 SEQADV 4UYO GLY A -8 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS A -7 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS A -6 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS A -5 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS A -4 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS A -3 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS A -2 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO GLU A -1 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO LEU A 0 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO CYS A 41 UNP P0ABN1 ALA 42 ENGINEERED MUTATION SEQADV 4UYO ALA A 46 UNP P0ABN1 CYS 47 ENGINEERED MUTATION SEQADV 4UYO VAL A 53 UNP P0ABN1 ILE 54 ENGINEERED MUTATION SEQADV 4UYO LEU A 70 UNP P0ABN1 ILE 71 ENGINEERED MUTATION SEQADV 4UYO LEU A 96 UNP P0ABN1 MET 97 ENGINEERED MUTATION SEQADV 4UYO ASP A 107 UNP P0ABN1 VAL 108 ENGINEERED MUTATION SEQADV 4UYO ALA A 113 UNP P0ABN1 CYS 114 ENGINEERED MUTATION SEQADV 4UYO GLY B -8 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS B -7 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS B -6 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS B -5 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS B -4 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS B -3 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS B -2 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO GLU B -1 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO LEU B 0 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO CYS B 41 UNP P0ABN1 ALA 42 ENGINEERED MUTATION SEQADV 4UYO ALA B 46 UNP P0ABN1 CYS 47 ENGINEERED MUTATION SEQADV 4UYO VAL B 53 UNP P0ABN1 ILE 54 ENGINEERED MUTATION SEQADV 4UYO LEU B 70 UNP P0ABN1 ILE 71 ENGINEERED MUTATION SEQADV 4UYO LEU B 96 UNP P0ABN1 MET 97 ENGINEERED MUTATION SEQADV 4UYO ASP B 107 UNP P0ABN1 VAL 108 ENGINEERED MUTATION SEQADV 4UYO ALA B 113 UNP P0ABN1 CYS 114 ENGINEERED MUTATION SEQADV 4UYO GLY C -8 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS C -7 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS C -6 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS C -5 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS C -4 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS C -3 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS C -2 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO GLU C -1 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO LEU C 0 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO CYS C 41 UNP P0ABN1 ALA 42 ENGINEERED MUTATION SEQADV 4UYO ALA C 46 UNP P0ABN1 CYS 47 ENGINEERED MUTATION SEQADV 4UYO VAL C 53 UNP P0ABN1 ILE 54 ENGINEERED MUTATION SEQADV 4UYO LEU C 70 UNP P0ABN1 ILE 71 ENGINEERED MUTATION SEQADV 4UYO LEU C 96 UNP P0ABN1 MET 97 ENGINEERED MUTATION SEQADV 4UYO ASP C 107 UNP P0ABN1 VAL 108 ENGINEERED MUTATION SEQADV 4UYO ALA C 113 UNP P0ABN1 CYS 114 ENGINEERED MUTATION SEQADV 4UYO GLY D -8 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS D -7 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS D -6 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS D -5 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS D -4 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS D -3 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS D -2 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO GLU D -1 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO LEU D 0 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO CYS D 41 UNP P0ABN1 ALA 42 ENGINEERED MUTATION SEQADV 4UYO ALA D 46 UNP P0ABN1 CYS 47 ENGINEERED MUTATION SEQADV 4UYO VAL D 53 UNP P0ABN1 ILE 54 ENGINEERED MUTATION SEQADV 4UYO LEU D 70 UNP P0ABN1 ILE 71 ENGINEERED MUTATION SEQADV 4UYO LEU D 96 UNP P0ABN1 MET 97 ENGINEERED MUTATION SEQADV 4UYO ASP D 107 UNP P0ABN1 VAL 108 ENGINEERED MUTATION SEQADV 4UYO ALA D 113 UNP P0ABN1 CYS 114 ENGINEERED MUTATION SEQADV 4UYO GLY E -8 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS E -7 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS E -6 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS E -5 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS E -4 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS E -3 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS E -2 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO GLU E -1 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO LEU E 0 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO CYS E 41 UNP P0ABN1 ALA 42 ENGINEERED MUTATION SEQADV 4UYO ALA E 46 UNP P0ABN1 CYS 47 ENGINEERED MUTATION SEQADV 4UYO VAL E 53 UNP P0ABN1 ILE 54 ENGINEERED MUTATION SEQADV 4UYO LEU E 70 UNP P0ABN1 ILE 71 ENGINEERED MUTATION SEQADV 4UYO LEU E 96 UNP P0ABN1 MET 97 ENGINEERED MUTATION SEQADV 4UYO ASP E 107 UNP P0ABN1 VAL 108 ENGINEERED MUTATION SEQADV 4UYO ALA E 113 UNP P0ABN1 CYS 114 ENGINEERED MUTATION SEQADV 4UYO GLY F -8 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS F -7 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS F -6 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS F -5 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS F -4 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS F -3 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO HIS F -2 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO GLU F -1 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO LEU F 0 UNP P0ABN1 EXPRESSION TAG SEQADV 4UYO CYS F 41 UNP P0ABN1 ALA 42 ENGINEERED MUTATION SEQADV 4UYO ALA F 46 UNP P0ABN1 CYS 47 ENGINEERED MUTATION SEQADV 4UYO VAL F 53 UNP P0ABN1 ILE 54 ENGINEERED MUTATION SEQADV 4UYO LEU F 70 UNP P0ABN1 ILE 71 ENGINEERED MUTATION SEQADV 4UYO LEU F 96 UNP P0ABN1 MET 97 ENGINEERED MUTATION SEQADV 4UYO ASP F 107 UNP P0ABN1 VAL 108 ENGINEERED MUTATION SEQADV 4UYO ALA F 113 UNP P0ABN1 CYS 114 ENGINEERED MUTATION SEQRES 1 A 130 GLY HIS HIS HIS HIS HIS HIS GLU LEU ALA ASN ASN THR SEQRES 2 A 130 THR GLY PHE THR ARG ILE ILE LYS ALA ALA GLY TYR SER SEQRES 3 A 130 TRP LYS GLY LEU ARG ALA ALA TRP ILE ASN GLU ALA ALA SEQRES 4 A 130 PHE ARG GLN GLU GLY VAL ALA VAL LEU LEU CYS VAL VAL SEQRES 5 A 130 ILE ALA ALA TRP LEU ASP VAL ASP ALA VAL THR ARG VAL SEQRES 6 A 130 LEU LEU ILE SER SER VAL MET LEU VAL MET ILE VAL GLU SEQRES 7 A 130 LEU LEU ASN SER ALA ILE GLU ALA VAL VAL ASP ARG ILE SEQRES 8 A 130 GLY SER GLU TYR HIS GLU LEU SER GLY ARG ALA LYS ASP SEQRES 9 A 130 LEU GLY SER ALA ALA VAL LEU ILE ALA ILE ILE ASP ALA SEQRES 10 A 130 VAL ILE THR TRP ALA ILE LEU LEU TRP SER HIS PHE GLY SEQRES 1 B 130 GLY HIS HIS HIS HIS HIS HIS GLU LEU ALA ASN ASN THR SEQRES 2 B 130 THR GLY PHE THR ARG ILE ILE LYS ALA ALA GLY TYR SER SEQRES 3 B 130 TRP LYS GLY LEU ARG ALA ALA TRP ILE ASN GLU ALA ALA SEQRES 4 B 130 PHE ARG GLN GLU GLY VAL ALA VAL LEU LEU CYS VAL VAL SEQRES 5 B 130 ILE ALA ALA TRP LEU ASP VAL ASP ALA VAL THR ARG VAL SEQRES 6 B 130 LEU LEU ILE SER SER VAL MET LEU VAL MET ILE VAL GLU SEQRES 7 B 130 LEU LEU ASN SER ALA ILE GLU ALA VAL VAL ASP ARG ILE SEQRES 8 B 130 GLY SER GLU TYR HIS GLU LEU SER GLY ARG ALA LYS ASP SEQRES 9 B 130 LEU GLY SER ALA ALA VAL LEU ILE ALA ILE ILE ASP ALA SEQRES 10 B 130 VAL ILE THR TRP ALA ILE LEU LEU TRP SER HIS PHE GLY SEQRES 1 C 130 GLY HIS HIS HIS HIS HIS HIS GLU LEU ALA ASN ASN THR SEQRES 2 C 130 THR GLY PHE THR ARG ILE ILE LYS ALA ALA GLY TYR SER SEQRES 3 C 130 TRP LYS GLY LEU ARG ALA ALA TRP ILE ASN GLU ALA ALA SEQRES 4 C 130 PHE ARG GLN GLU GLY VAL ALA VAL LEU LEU CYS VAL VAL SEQRES 5 C 130 ILE ALA ALA TRP LEU ASP VAL ASP ALA VAL THR ARG VAL SEQRES 6 C 130 LEU LEU ILE SER SER VAL MET LEU VAL MET ILE VAL GLU SEQRES 7 C 130 LEU LEU ASN SER ALA ILE GLU ALA VAL VAL ASP ARG ILE SEQRES 8 C 130 GLY SER GLU TYR HIS GLU LEU SER GLY ARG ALA LYS ASP SEQRES 9 C 130 LEU GLY SER ALA ALA VAL LEU ILE ALA ILE ILE ASP ALA SEQRES 10 C 130 VAL ILE THR TRP ALA ILE LEU LEU TRP SER HIS PHE GLY SEQRES 1 D 130 GLY HIS HIS HIS HIS HIS HIS GLU LEU ALA ASN ASN THR SEQRES 2 D 130 THR GLY PHE THR ARG ILE ILE LYS ALA ALA GLY TYR SER SEQRES 3 D 130 TRP LYS GLY LEU ARG ALA ALA TRP ILE ASN GLU ALA ALA SEQRES 4 D 130 PHE ARG GLN GLU GLY VAL ALA VAL LEU LEU CYS VAL VAL SEQRES 5 D 130 ILE ALA ALA TRP LEU ASP VAL ASP ALA VAL THR ARG VAL SEQRES 6 D 130 LEU LEU ILE SER SER VAL MET LEU VAL MET ILE VAL GLU SEQRES 7 D 130 LEU LEU ASN SER ALA ILE GLU ALA VAL VAL ASP ARG ILE SEQRES 8 D 130 GLY SER GLU TYR HIS GLU LEU SER GLY ARG ALA LYS ASP SEQRES 9 D 130 LEU GLY SER ALA ALA VAL LEU ILE ALA ILE ILE ASP ALA SEQRES 10 D 130 VAL ILE THR TRP ALA ILE LEU LEU TRP SER HIS PHE GLY SEQRES 1 E 130 GLY HIS HIS HIS HIS HIS HIS GLU LEU ALA ASN ASN THR SEQRES 2 E 130 THR GLY PHE THR ARG ILE ILE LYS ALA ALA GLY TYR SER SEQRES 3 E 130 TRP LYS GLY LEU ARG ALA ALA TRP ILE ASN GLU ALA ALA SEQRES 4 E 130 PHE ARG GLN GLU GLY VAL ALA VAL LEU LEU CYS VAL VAL SEQRES 5 E 130 ILE ALA ALA TRP LEU ASP VAL ASP ALA VAL THR ARG VAL SEQRES 6 E 130 LEU LEU ILE SER SER VAL MET LEU VAL MET ILE VAL GLU SEQRES 7 E 130 LEU LEU ASN SER ALA ILE GLU ALA VAL VAL ASP ARG ILE SEQRES 8 E 130 GLY SER GLU TYR HIS GLU LEU SER GLY ARG ALA LYS ASP SEQRES 9 E 130 LEU GLY SER ALA ALA VAL LEU ILE ALA ILE ILE ASP ALA SEQRES 10 E 130 VAL ILE THR TRP ALA ILE LEU LEU TRP SER HIS PHE GLY SEQRES 1 F 130 GLY HIS HIS HIS HIS HIS HIS GLU LEU ALA ASN ASN THR SEQRES 2 F 130 THR GLY PHE THR ARG ILE ILE LYS ALA ALA GLY TYR SER SEQRES 3 F 130 TRP LYS GLY LEU ARG ALA ALA TRP ILE ASN GLU ALA ALA SEQRES 4 F 130 PHE ARG GLN GLU GLY VAL ALA VAL LEU LEU CYS VAL VAL SEQRES 5 F 130 ILE ALA ALA TRP LEU ASP VAL ASP ALA VAL THR ARG VAL SEQRES 6 F 130 LEU LEU ILE SER SER VAL MET LEU VAL MET ILE VAL GLU SEQRES 7 F 130 LEU LEU ASN SER ALA ILE GLU ALA VAL VAL ASP ARG ILE SEQRES 8 F 130 GLY SER GLU TYR HIS GLU LEU SER GLY ARG ALA LYS ASP SEQRES 9 F 130 LEU GLY SER ALA ALA VAL LEU ILE ALA ILE ILE ASP ALA SEQRES 10 F 130 VAL ILE THR TRP ALA ILE LEU LEU TRP SER HIS PHE GLY HET 79N A1122 23 HET 79M B1122 23 HET 79N B1123 23 HET 79M B1124 23 HET 79N C1122 23 HET ZN D1122 1 HET 79N D1123 23 HET 79N D1124 23 HET 79M D1125 23 HET FLC D1126 13 HET 79M F1121 23 HETNAM 79N (2S)-2,3-DIHYDROXYPROPYL (7Z)-HEXADEC-7-ENOATE HETNAM 79M (2R)-2,3-DIHYDROXYPROPYL (7Z)-HEXADEC-7-ENOATE HETNAM ZN ZINC ION HETNAM FLC CITRATE ANION HETSYN 79M [(2R)-2,3-BIS(OXIDANYL)PROPYL] (Z)-HEXADEC-7-ENOATE FORMUL 7 79N 5(C19 H36 O4) FORMUL 8 79M 4(C19 H36 O4) FORMUL 12 ZN ZN 2+ FORMUL 16 FLC C6 H5 O7 3- FORMUL 18 HOH *85(H2 O) HELIX 1 1 GLY A 6 GLU A 28 1 23 HELIX 2 2 GLU A 28 TRP A 47 1 20 HELIX 3 3 ASP A 51 GLY A 83 1 33 HELIX 4 4 HIS A 87 GLY A 121 1 35 HELIX 5 5 GLU B 28 LEU B 48 1 21 HELIX 6 6 ASP B 51 GLY B 83 1 33 HELIX 7 7 HIS B 87 GLY B 121 1 35 HELIX 8 8 GLN C 33 LEU C 48 1 16 HELIX 9 9 ASP C 51 GLY C 83 1 33 HELIX 10 10 HIS C 87 PHE C 120 1 34 HELIX 11 11 TYR D 16 GLU D 28 1 13 HELIX 12 12 GLU D 28 LEU D 48 1 21 HELIX 13 13 ASP D 51 GLY D 83 1 33 HELIX 14 14 HIS D 87 GLY D 121 1 35 HELIX 15 15 TYR E 16 TRP E 25 1 10 HELIX 16 16 ARG E 32 LEU E 48 1 17 HELIX 17 17 ASP E 51 ASP E 80 1 30 HELIX 18 18 GLY E 83 HIS E 87 5 5 HELIX 19 19 SER E 90 SER E 118 1 29 HELIX 20 20 GLU F 28 ALA F 46 1 19 HELIX 21 21 ASP F 51 HIS F 87 1 37 HELIX 22 22 ARG F 92 PHE F 120 1 29 LINK OE1 GLU D 28 ZN ZN D1122 1555 1555 2.10 LINK OE2 GLU D 28 ZN ZN D1122 1555 1555 2.11 LINK OE1 GLU D 76 ZN ZN D1122 1555 1555 2.04 LINK OE2 GLU D 76 ZN ZN D1122 1555 1555 2.14 LINK ZN ZN D1122 OA2 FLC D1126 1555 1555 1.95 LINK ZN ZN D1122 O HOH D2004 1555 1555 2.16 SITE 1 AC1 3 LEU A 21 ARG A 22 TRP A 25 SITE 1 AC2 8 ALA B 46 VAL B 50 ALA B 52 ARG B 55 SITE 2 AC2 8 ILE C 114 TRP C 117 GLN D 33 79N D1123 SITE 1 AC3 5 GLU B 34 CYS B 41 VAL B 62 GLU B 69 SITE 2 AC3 5 TRP B 112 SITE 1 AC4 5 ASP B 49 GLN D 33 GLU D 34 ILE D 105 SITE 2 AC4 5 VAL D 109 SITE 1 AC5 5 LEU A 39 LEU A 40 GLU C 34 GLU C 69 SITE 2 AC5 5 TRP C 112 SITE 1 AC6 8 GLN A 33 79M B1122 TRP C 117 TRP D 25 SITE 2 AC6 8 ALA D 29 ARG D 32 VAL D 36 79M D1125 SITE 1 AC7 7 ILE B 26 ARG B 32 GLY B 35 TRP D 47 SITE 2 AC7 7 LEU D 48 ASP D 49 PHE D 120 SITE 1 AC8 6 GLU A 34 GLU A 69 VAL A 101 TRP D 25 SITE 2 AC8 6 LEU D 39 79N D1123 SITE 1 AC9 7 GLU F 34 GLU F 69 ILE F 105 ALA F 108 SITE 2 AC9 7 VAL F 109 TRP F 112 LEU F 116 SITE 1 BC1 4 GLU D 28 GLU D 76 FLC D1126 HOH D2004 SITE 1 BC2 7 GLU D 28 GLU D 76 ZN D1122 HOH D2004 SITE 2 BC2 7 HOH D2028 HOH D2029 HOH D2030 CRYST1 75.300 91.800 141.700 90.00 90.00 90.00 P 21 21 21 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013280 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010893 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007057 0.00000